91 related articles for article (PubMed ID: 26285227)
1. Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease.
Memedi M; Nyholm D; Johansson A; Pålhagen S; Willows T; Widner H; Linder J; Westin J
IEEE J Biomed Health Inform; 2015 Nov; 19(6):1829-34. PubMed ID: 26285227
[TBL] [Abstract][Full Text] [Related]
2. Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.
Pålhagen SE; Sydow O; Johansson A; Nyholm D; Holmberg B; Widner H; Dizdar N; Linder J; Hauge T; Jansson R; Bergmann L; Kjellander S; Marshall TS
Parkinsonism Relat Disord; 2016 Aug; 29():17-23. PubMed ID: 27318707
[TBL] [Abstract][Full Text] [Related]
3. [The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease].
Kovács N; Aschermann Z; Ács P; Bosnyák E; Deli G; Janszky J; Komoly S
Ideggyogy Sz; 2014 Jul; 67(7-8):245-50. PubMed ID: 25509365
[TBL] [Abstract][Full Text] [Related]
4. Long-term safety and maintenance of efficacy of levodopa-carbidopa intestinal gel: an open-label extension of the double-blind pivotal study in advanced Parkinson's disease patients.
Slevin JT; Fernandez HH; Zadikoff C; Hall C; Eaton S; Dubow J; Chatamra K; Benesh J
J Parkinsons Dis; 2015; 5(1):165-74. PubMed ID: 25588353
[TBL] [Abstract][Full Text] [Related]
5. Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety.
Othman AA; Chatamra K; Mohamed ME; Dutta S; Benesh J; Yanagawa M; Nagai M
Clin Pharmacokinet; 2015 Sep; 54(9):975-84. PubMed ID: 25875940
[TBL] [Abstract][Full Text] [Related]
6. A new computer method for assessing drawing impairment in Parkinson's disease.
Westin J; Ghiamati S; Memedi M; Nyholm D; Johansson A; Dougherty M; Groth T
J Neurosci Methods; 2010 Jun; 190(1):143-8. PubMed ID: 20438759
[TBL] [Abstract][Full Text] [Related]
7. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.
Zibetti M; Rizzone M; Merola A; Angrisano S; Rizzi L; Montanaro E; Cicolin A; Lopiano L
Acta Neurol Scand; 2013 May; 127(5):e28-32. PubMed ID: 23311399
[TBL] [Abstract][Full Text] [Related]
8. Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.
Solla P; Fasano A; Cannas A; Mulas CS; Marrosu MG; Lang AE; Marrosu F
Parkinsonism Relat Disord; 2015 Aug; 21(8):968-71. PubMed ID: 26071817
[TBL] [Abstract][Full Text] [Related]
9. Prospective study on cost-effectiveness of home-based motor assessment in Parkinson's disease.
Cubo E; Mariscal N; Solano B; Becerra V; Armesto D; Calvo S; Arribas J; Seco J; Martinez A; Zorrilla L; Heldman D
J Telemed Telecare; 2017 Feb; 23(2):328-338. PubMed ID: 27000142
[TBL] [Abstract][Full Text] [Related]
10. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
[TBL] [Abstract][Full Text] [Related]
11. Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience.
Zibetti M; Merola A; Artusi CA; Rizzi L; Angrisano S; Reggio D; De Angelis C; Rizzone M; Lopiano L
Eur J Neurol; 2014 Feb; 21(2):312-8. PubMed ID: 24313838
[TBL] [Abstract][Full Text] [Related]
12. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
[TBL] [Abstract][Full Text] [Related]
13. Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease.
Pålhagen SE; Dizdar N; Hauge T; Holmberg B; Jansson R; Linder J; Nyholm D; Sydow O; Wainwright M; Widner H; Johansson A
Acta Neurol Scand; 2012 Dec; 126(6):e29-33. PubMed ID: 22690905
[TBL] [Abstract][Full Text] [Related]
14. A home environment test battery for status assessment in patients with advanced Parkinson's disease.
Westin J; Dougherty M; Nyholm D; Groth T
Comput Methods Programs Biomed; 2010 Apr; 98(1):27-35. PubMed ID: 19740563
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a timed motor test battery to the Unified Parkinson's Disease Rating Scale-III in Parkinson's disease.
Haaxma CA; Bloem BR; Borm GF; Horstink MW
Mov Disord; 2008 Sep; 23(12):1707-17. PubMed ID: 18649395
[TBL] [Abstract][Full Text] [Related]
16. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].
Litvinenko IV; Odinak MM; Mogil'naia VI; Sologub OS; Sakharovskaia AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):51-4. PubMed ID: 19156087
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
[TBL] [Abstract][Full Text] [Related]
19. Quantitative measurements of alternating finger tapping in Parkinson's disease correlate with UPDRS motor disability and reveal the improvement in fine motor control from medication and deep brain stimulation.
Taylor Tavares AL; Jefferis GS; Koop M; Hill BC; Hastie T; Heit G; Bronte-Stewart HM
Mov Disord; 2005 Oct; 20(10):1286-98. PubMed ID: 16001401
[TBL] [Abstract][Full Text] [Related]
20. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review.
Ghika J; Villemure JG; Fankhauser H; Favre J; Assal G; Ghika-Schmid F
J Neurosurg; 1998 Nov; 89(5):713-8. PubMed ID: 9817406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
